Which hedge funds own BOLDEUR? AUDENTES THERAPEUTICS INC, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in BOLDEUR (AUDENTES THERAPEUTICS INC) in their Q2 2026 13F filings, worth $0 in total.
- 0
- Holders
- 0
- New this quarter
- 0
- Exited this quarter
- $0
- Combined value
- –
- Share of managers holding
Holders, Q2 2026
Ownership over time
By quarter
| Quarter | Holders | Managers filing | Share holding | Combined value |
|---|---|---|---|---|
| Q1 2020 | 0 | 68 | 0.0% | $0 |
| Q4 2019 | 8 | 67 | 11.9% | $247m |
| Q3 2019 | 3 | 60 | 5.0% | $33.1m |
| Q2 2019 | 3 | 60 | 5.0% | $45.3m |
| Q1 2019 | 2 | 60 | 3.3% | $50.1m |
| Q4 2018 | 2 | 60 | 3.3% | $28.2m |
| Q3 2018 | 1 | 59 | 1.7% | $24.7m |
| Q2 2018 | 2 | 59 | 3.4% | $17.8m |
| Q1 2018 | 4 | 59 | 6.8% | $25.9m |
| Q4 2017 | 3 | 59 | 5.1% | $24.2m |
| Q3 2017 | 1 | 56 | 1.8% | $11.2m |
| Q2 2017 | 2 | 56 | 3.6% | $13.8m |
| Q1 2017 | 2 | 56 | 3.6% | $13.5m |
| Q4 2016 | 1 | 56 | 1.8% | $9.7m |
| Q3 2016 | 1 | 52 | 1.9% | $12.6m |
Who discovered BOLDEUR first?
Earliest meaningful positions among the 9 tracked managers seen opening BOLDEUR since Q3 2016.
| RA Capital Management, L.P. | Q3 2016 | 1.3% | Exited by Q1 2020 | +236% |
| Casdin Capital, LLC | Q1 2017 | 2.6% | Exited by Q1 2020 | +251% |
| Tudor Investment Corp ET AL | Q1 2018 | 0.03% | Exited by Q1 2020 | +99% |
Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.